Limbix (by BigHealth)
Evidence-based digital therapeutics for adolescent mental health and behavioral activation.
Advanced Digital Respiratory Health Management and Connected Inhaler Ecosystem
Cohero Health, now part of the Aptar Digital Health ecosystem in 2026, provides a comprehensive digital therapeutic platform specifically designed for chronic respiratory diseases like Asthma and COPD. The architecture integrates hardware and software through the HeroTracker® smart sensors and mobile spirometers, which connect via Bluetooth Low Energy (BLE) to the BreatheSmart mobile application. This technical ecosystem captures real-time medication usage data and lung function metrics (FEV1/FVC), syncing them to a HIPAA-compliant cloud environment. The platform leverages predictive analytics to identify early signs of patient deterioration, allowing for proactive clinical intervention. In the 2026 market, Cohero stands out for its high-fidelity data integration into existing clinical workflows via HL7 and FHIR protocols, making it a staple for clinical trials and large-scale population health management. By closing the loop between patient behavior and clinical outcomes, the platform optimizes medication adherence—often reaching levels 2-3x higher than the industry average—while reducing emergency room visits and healthcare utilization costs for enterprise stakeholders.
Proprietary optical and mechanical sensors that attach to standard pressurized metered-dose inhalers (pMDIs) to record date, time, and quality of actuation.
Evidence-based digital therapeutics for adolescent mental health and behavioral activation.
Scaleable AI-driven chronic disease management and prevention through conversational coaching.
AI-driven primary care platform revolutionizing patient triage and digital health delivery.
FDA-cleared digital therapeutics leveraging AI-driven neuro-gaming to treat cognitive dysfunction.
Verified feedback from the global deployment network.
Post queries, share implementation strategies, and help other users.
Handheld spirometers measuring FEV1, FVC, and PEF with clinical-grade accuracy, synced directly to the cloud.
Machine learning models that analyze the correlation between declining lung function and increased rescue inhaler usage.
Data structure built on HL7 FHIR standards for seamless interoperability with Epic, Cerner, and Athenahealth.
Behavioral science-driven app interface that uses reward loops to encourage medication adherence.
Full SDK and API access allowing pharmaceutical companies to skin the interface for specific brands.
Secure dashboard providing a stratified view of high-risk versus stable patients based on real-time data.
Low reliability of patient self-reported medication logs in respiratory drug trials.
Registry Updated:2/7/2026
High emergency room visit rates due to poor adherence in children.
High costs associated with 30-day readmissions after exacerbations.